‘The Art of the Heal’: How TrumpRx, Most-Favored Nation Pricing, Big Pharma Intersect
(The Center Square) – AstraZeneca has now joined Pfizer in agreeing to sell its drugs to state Medicaid programs at “most-favored-nation” ...
(The Center Square) – AstraZeneca has now joined Pfizer in agreeing to sell its drugs to state Medicaid programs at “most-favored-nation” ...
In a dramatic escalation of his “America First” agenda, President Donald Trump announced a sweeping new agreement with pharmaceutical giant ...
BioNTech's Dr. Ugur Sahin topped Fierce Pharma's 2024 list with $287 million, while Pfizer's Albert Bourla ($24.6 million) and Eli Lilly's ...